Status:
TERMINATED
Continuous TAP Blocks - Pain & Plasma LA Levels
Lead Sponsor:
University of Alberta
Conditions:
Nerve Block
Pain, Postoperative
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to establish an alternative method of postoperative pain control to the current standard of practice, patient-controlled analgesia with intravenous opioids, for patients u...
Detailed Description
INTRODUCTION The use of peripheral nerve blocks has become increasingly popular in the last two decades. With the use of anatomical landmark-based techniques, peripheral nerve stimulators, or ultrasou...
Eligibility Criteria
Inclusion
- Adult patients undergoing major abdominal surgery who consent to a continuous transversus abdominis nerve block as part of their postoperative management
Exclusion
- History of allergy to local anesthesia
- Infection in the area of intended catheter insertion
- Opiate tolerance
- Failure to consent
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT01871168
Start Date
May 1 2013
End Date
November 1 2017
Last Update
March 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta Hospital
Edmonton, Alberta, Canada, T6G 2G3